Barbara Walley

机构：University of Calgary, Queen's University, Alberta Cancer Foundation · ORCID：0000-0002-9618-905X

发表论文 47 篇 · 总被引 3863 次 · h-index 21

代表论文

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer (2018 · New England Journal of Medicine · 被引 685)
Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials (2016 · Journal of Clinical Oncology · 被引 184)
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials (2015 · The Lancet Oncology · 被引 179)
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials (2022 · Journal of Clinical Oncology · 被引 161)
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT (2019 · Journal of Clinical Oncology · 被引 150)
Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials (2017 · Journal of Clinical Oncology · 被引 150)